CUMBERLAND PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Nashville,, TN
SEC filing record 1 source field available
Fiscal year end
31 December
CUMBERLAND PHARMACEUTICALS INC has filed 1,032 SEC EDGAR filings since 02 May 2002

SEC filing history

Showing 651-675 of 959 matching filings.

Per page
25
Current page
27
CT ORDER File 001-33637

CT ORDER filing

Filing date
26 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Apr 2016
Reporting date
06 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Apr 2016
Reporting date
06 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Apr 2016
Reporting date
06 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Apr 2016
Reporting date
06 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Apr 2016
Reporting date
06 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Apr 2016
Reporting date
06 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Apr 2016
Reporting date
06 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Apr 2016
Reporting date
06 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Apr 2016
Reporting date
06 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Apr 2016
Reporting date
17 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85205

SC13GA CUMBERLAND PHARMA MAR16

Filing date
08 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33637

DEFA14A

Filing date
29 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33637

DEF 14A 03162016

Filing date
16 Mar 2016
Reporting date
26 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K

Filing date
09 Mar 2016
Reporting date
09 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
18 Feb 2016
Reporting date
08 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85205

SC 13G

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
12 Feb 2016
Reporting date
01 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85205

SC13GA CUMBERLAND PHARMA DEC15

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85205

SCHEDULE 13G

Filing date
09 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K

Filing date
05 Feb 2016
Reporting date
05 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K MBONNERCFOAPPOINTMENT

Filing date
01 Feb 2016
Reporting date
29 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Dec 2015
Reporting date
28 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Dec 2015
Reporting date
02 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .